Two new antivirals for HIV will be approved soon
December 1996
Two new antivirals for HIV will be approved soon...Rescriptor (delavirdine) and Viracept (nelfinavir).
Rescriptor will be the second non-nucleoside reverse transcriptase inhibitor (NNRTI)...similar to Viramune (nevirapine).
The NNRTIs aren't as powerful as the protease inhibitors. But they have a niche in combo therapy...by boosting the efficacy of nucleosides such as AZT (Retrovir), 3TC (Epivir), etc.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote